Three Channel Food Concept: the Effect Meal Service on Food Intake During Hospitalization

April 30, 2024 updated by: Maastricht University Medical Center

Three Channel Food Concept: the Effect on Food Intake During Hospitalization (Dutch: Het Driekanalenconcept: Het Effect op Voedingsinname Tijdens Ziekenhuisopname)

The goal of this observational study is to assess food intake in hospitalized patients.

The present study will evaluate the impact of a novel in-hospital meal concept (three channel food concept) on total energy and protein intake, macronutrient distribution, and patient appreciation

Food intake will be assessed (as part of usual care) by weighing all leftovers (e.g. food that patients did not consume).

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

There are various possible strategies to increase protein intake during hospitalization, such as providing more protein-rich foods, fortifying meals and/or food products, supplementation with oral nutritional supplements (ONS), and/or providing well-timed snacks. An appropriate in-hospital meal service is regarded as a key element of the strategy to minimize deterioration of the nutritional status. Conventional hospital meals, 3 main meals a day prepared by a central kitchen, are often low in protein and energy and are not appreciated by patients due to lack of taste, colour and flavour, resulting in inadequate food intake particularly protein intake. There are a number of avenues to improve nutritional intake, with type of meal service and existence of individual contact with catering staff, like mealtime assistance, as important factors. The MUMC+ has adapted it's in-hospital meal system and the present study will evaluate the impact of this novel in-hospital meal concept (three channel food concept) on total energy and protein intake, macronutrient distribution, and patient appreciation.

The aim of this study is to assess whether a novel in-hospital meal concept can effectively increase daily total protein and energy intake during hospitalization, when compared to a historic control.

Study Type

Observational

Enrollment (Estimated)

102

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients (>18y) admitted to surgery nursing wards of the Maastricht University Medical Centre+ (MUMC+).

Description

Inclusion Criteria:

  • >18y
  • Admitted to surgical nursing wards of MUMC+
  • Expected hospital stay of at least 3 days

Exclusion Criteria:

  • Receiving (par)enteral nutrition
  • "NPO" (nil per os) policy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
current in-hospital meal service
n=102 patients admitted to the Maastricht University Medical Centre+ (MUMC+) (surgical nursing wards) will be included.
We're not subjecting patients to an intervention, as we will evaluate the current in-hospital meal service. As the three channel food concept is standard of care, we're not subjecting patients to dietary or behavioral changes. We will compare the data to an historic control.
old in-hospital meal service
This will be an historic control group (data already collected in the past)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
total protein intake
Time Frame: during hospitalization (minimal 2days max 5days)
total protein intake (g/kg/d)
during hospitalization (minimal 2days max 5days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
total energy intake
Time Frame: during hospitalization (minimal 2days max 5days)
energy intake in kcal per day
during hospitalization (minimal 2days max 5days)
macronutrient intake
Time Frame: during hospitalization (minimal 2days max 5days)
carbohydrate, fat and protein intake (g/day)
during hospitalization (minimal 2days max 5days)
Patient appreciation
Time Frame: during hospitalization (minimal 2days max 5days)
Patient appreciation will be assessed using a question "what grade would you give the hospital food
during hospitalization (minimal 2days max 5days)
Body weight upon hospital admission
Time Frame: upon hospital admission
body weight in kilograms
upon hospital admission
Body height upon hospital admission
Time Frame: upon hospital admission
body height in meters
upon hospital admission
reason hospital admission
Time Frame: upon hospital admission
will be derived from electronical patient dossier
upon hospital admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luc JC van Loon, PhD, Maastricht University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

March 5, 2024

First Submitted That Met QC Criteria

April 30, 2024

First Posted (Actual)

May 3, 2024

Study Record Updates

Last Update Posted (Actual)

May 3, 2024

Last Update Submitted That Met QC Criteria

April 30, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 302653

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Individual raw data can be shared upon reasonable request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe